ObsEva SA (OBSV)

[Theo]

"Repost [Pivot to Valuation] Many here are wondering why the stock price has not appreciated significantly yet. The Company does not generate revenue yet, and its lead product, pipeline have yet to be approved anywhere in the world. The real valuation will come in phases (IMO) - Linzagolix approval in MAA, approval in US (FDA) - followed by first revenue-generating contract(s) on the product. Subsequent approval on Linzagolix (Endometriosis) and/or Ebopiprant will generate sizeable, incremental value here. Major catalysts are coming here in Q4, which setup a strong 2022 potentially for OBSV (IMO).
© 2021 InvestorsHub.com, Inc. "

Precisely and is why I sold out 2-3 months ago- #msg-165137134 & especially this post #msg-165145133

I still believe there is money to be made here...just not now. {Major catalysts are coming here in Q4, which setup a strong 2022 potentially for OBSV}- My hope was that approval/revenue would start earlier than later. My biggest fear was, and has ALWAYS been, that if they didn't start producing revenue "soon", they would need to raise more cash- something I see happening shortly. I would rather wait to see when and how much they dilute before taking back a position.

I still keep my eye on this